indomethacin has been researched along with Alveolar Bone Atrophy in 9 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We examined the effects of calcium gluconate, an anti-inflammatory calcium salt, on ligature-induced experimental periodontitis and related alveolar bone loss." | 7.77 | Effects of calcium gluconate on experimental periodontitis and alveolar bone loss in rats. ( Cho, HR; Kang, SJ; Ku, SK; Lee, YJ; Sung, YS, 2011) |
| "We investigated the effect of etoricoxib, a selective cyclooxygenase-2 inhibitor, and indomethacin, a non-selective cyclooxygenase inhibitor, on experimental periodontitis, and compared their gastrointestinal side effects." | 7.74 | Comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in rats. ( Azoubel, MC; Bezerra, D; Brito, GA; Menezes, AM; Oriá, RB; Ribeiro, RA, 2007) |
| "We examined the effects of calcium gluconate, an anti-inflammatory calcium salt, on ligature-induced experimental periodontitis and related alveolar bone loss." | 3.77 | Effects of calcium gluconate on experimental periodontitis and alveolar bone loss in rats. ( Cho, HR; Kang, SJ; Ku, SK; Lee, YJ; Sung, YS, 2011) |
| "We investigated the effect of etoricoxib, a selective cyclooxygenase-2 inhibitor, and indomethacin, a non-selective cyclooxygenase inhibitor, on experimental periodontitis, and compared their gastrointestinal side effects." | 3.74 | Comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in rats. ( Azoubel, MC; Bezerra, D; Brito, GA; Menezes, AM; Oriá, RB; Ribeiro, RA, 2007) |
| "Arachidonic acid metabolites have been implicated in development of periodontal disease, especially those derived from the cyclo-oxygenase (COX) pathway." | 1.35 | Role of systemic and local administration of selective inhibitors of cyclo-oxygenase 1 and 2 in an experimental model of periodontal disease in rats. ( Caliari, MV; Duarte, ID; Francischi, JN; Maltos, KL; Pacheco, CM; Queiroz-Junior, CM, 2009) |
| "Indomethacin, which is a prostaglandin inhibitor, decreased the osteoclast formation induced by the bacterial sonicates." | 1.31 | Effects of whole cell sonicates of Treponema lecithinolyticum on osteoclast differentiation. ( Choi, BK; Jeong, GJ; Kang, JH; Lee, HJ; Ohk, SH; Yoo, YJ, 2001) |
| "Extracts of human periapical granulomas were tested for the presence of bone-resorbing activity." | 1.29 | Characterization of bone-resorbing activity in human periapical lesions. ( Stashenko, P; Wang, CY, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Queiroz-Junior, CM | 1 |
| Pacheco, CM | 1 |
| Maltos, KL | 1 |
| Caliari, MV | 1 |
| Duarte, ID | 1 |
| Francischi, JN | 1 |
| Ku, SK | 1 |
| Cho, HR | 1 |
| Sung, YS | 1 |
| Kang, SJ | 1 |
| Lee, YJ | 1 |
| Oka, H | 1 |
| Miyauchi, M | 1 |
| Furusho, H | 1 |
| Nishihara, T | 1 |
| Takata, T | 1 |
| Azoubel, MC | 1 |
| Menezes, AM | 1 |
| Bezerra, D | 1 |
| Oriá, RB | 1 |
| Ribeiro, RA | 2 |
| Brito, GA | 2 |
| Lasfargues, JJ | 1 |
| Saffar, JL | 1 |
| Howell, TH | 1 |
| Williams, RC | 1 |
| Wang, CY | 1 |
| Stashenko, P | 1 |
| Bezerra, MM | 1 |
| de Lima, V | 1 |
| Alencar, VB | 1 |
| Vieira, IB | 1 |
| Rocha, FA | 1 |
| Choi, BK | 1 |
| Ohk, SH | 1 |
| Lee, HJ | 1 |
| Kang, JH | 1 |
| Jeong, GJ | 1 |
| Yoo, YJ | 1 |
1 review available for indomethacin and Alveolar Bone Atrophy
| Article | Year |
|---|---|
Nonsteroidal antiinflammatory drugs as inhibitors of periodontal disease progression.
Topics: Alveolar Bone Loss; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Resorption; Flurbiprofen; | 1993 |
8 other studies available for indomethacin and Alveolar Bone Atrophy
| Article | Year |
|---|---|
Role of systemic and local administration of selective inhibitors of cyclo-oxygenase 1 and 2 in an experimental model of periodontal disease in rats.
Topics: Alveolar Bone Loss; Animals; Arachidonic Acid; Celecoxib; Cyclooxygenase Inhibitors; Disease Models, | 2009 |
Effects of calcium gluconate on experimental periodontitis and alveolar bone loss in rats.
Topics: Alveolar Bone Loss; Analysis of Variance; Animals; Anti-Inflammatory Agents; Body Weight; Calcium Gl | 2011 |
Oral administration of prostaglandin E(2)-specific receptor 4 antagonist inhibits lipopolysaccharide-induced osteoclastogenesis in rat periodontal tissue.
Topics: Aggregatibacter actinomycetemcomitans; Alveolar Bone Loss; Alveolar Process; Animals; Bone Resorptio | 2012 |
Comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in rats.
Topics: Alveolar Bone Loss; Animals; Cyclooxygenase Inhibitors; Etoricoxib; Female; Gastric Mucosa; Indometh | 2007 |
Inhibition of prostanoid synthesis depresses alveolar bone resorption but enhances root resorption in the rat.
Topics: Adaptation, Physiological; Alveolar Bone Loss; Animals; Dental Cementum; Indomethacin; Male; Osteocl | 1993 |
Characterization of bone-resorbing activity in human periapical lesions.
Topics: Alveolar Bone Loss; Analysis of Variance; Animals; Bone Resorption; Dinoprostone; Humans; Indomethac | 1993 |
Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats.
Topics: Alveolar Bone Loss; Alveolar Process; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; | 2000 |
Effects of whole cell sonicates of Treponema lecithinolyticum on osteoclast differentiation.
Topics: Alveolar Bone Loss; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Marrow Cells; Carrier Pro | 2001 |